People channel feed

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Yesterday
Pharma

KalVista CEO says FDA re­view pro­ceed­ed nor­mal­ly, was un­aware of Makary's re­jec­tion ask

Yesterday
Pharma
FDA+

4DMT lays off staff, reshuf­fles team as it dou­bles down on Phase 3 plans

6 days ago
R&D

Sage plans to lay off al­most every em­ploy­ee af­ter ink­ing Su­per­nus deal

Last week
Deals

Trump’s CDC nom­i­nee side­steps Sen­ate grilling on con­tro­ver­sial changes

Last week
Pharma

Bay­er's stem cell group Blue­Rock re­struc­tures pipeline, lays off staffers

2 weeks ago
Cell/Gene Tx

For­mer FDA sci­en­tist and psy­che­delics re­searcher hired as CDER deputy di­rec­tor

2 weeks ago
FDA+

Ex­clu­sive: Mikael Dol­sten joins gene edit­ing star­tup's board and eyes 'op­por­tu­ni­ties' with new FDA lead­ers

2 weeks ago
Startups

Act­ing CDER chief is leav­ing af­ter al­most nine years at FDA

3 weeks ago
FDA+

Iso­mor­phic to open US of­fice in Cam­bridge, hires ex-Re­lay CMO

4 weeks ago
AI

An­oth­er round of con­sol­i­da­tion is com­ing, FDA com­mis­sion­er tells staff

4 weeks ago
FDA+

Ver­tex lays off 125 work­ers af­ter type 1 di­a­betes cell ther­a­py failed study in March

4 weeks ago
Pharma
Cell/Gene Tx

For­mer a16z biotech in­vest­ment leader Vi­jay Pande ex­its the VC firm

5 weeks ago

Re­cur­sion to lay off 20% of staff, a month af­ter slash­ing its pipeline

5 weeks ago
AI

Biotech slump forces Re­silience to wind down six man­u­fac­tur­ing sites, us­ing bank­rupt­cy move

5 weeks ago
Manufacturing

Bio­phar­ma lead­ers carv­ing a path for the in­dus­try’s LGBTQ+ com­mu­ni­ty

Last month
Special

Ex-HHS work­ers ac­cuse Trump ad­min­is­tra­tion of us­ing flawed da­ta to is­sue fir­ings

Last month
Pharma
Law

Strug­gling biotechs suc­cumb to icy mar­ket, as mon­ey dries up and clin­i­cal bets don’t pay off

Last month
Pharma
In Focus

Q&A: San­doz CEO Richard Saynor on gener­ic GLP-1s, Trump's in­dus­try im­pact, and Mark Cuban's com­pa­ny

Last month
Pharma
Manufacturing

DOGE set to­day as their last day at FDA. In­stead, they're con­tin­u­ing to get full pay and don't work

Last month
FDA+

Q&A: Why for­mer Sen. Kyrsten Sine­ma is back­ing a psy­che­del­ic med­i­cine with po­ten­tial­ly more up­side, but more risk

Last month
R&D

In­sur­ance start­up De­vot­ed Health cuts 5% of work­ers in small lay­off

Last month
Startups
Health Tech

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

Last month
Startups

Ser­no­va chair re­signs fol­low­ing in­sid­er trad­ing in­dict­ment over No­var­tis-Chi­nook deal

Last month
Law
1234 Next page Last page
A service from the Financial Times